Fish oil could boost birth weight in HIV-Positive moms
NCT ID NCT06971445
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether taking omega-3 supplements (fish oil) for 8 weeks during pregnancy can help HIV-positive women on antiretroviral therapy have healthier babies. Researchers will measure birth weight, length of pregnancy, and inflammation levels. 92 pregnant women will be randomly assigned to receive either omega-3 or a placebo (olive oil).
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
omega-3 polyunsaturated fatty acids (EPA, DHA, ALA)
What this could lead to
If it works, this could point toward a simple dietary supplement to help HIV-positive women have healthier pregnancies and babies.
What could go wrong
This is a small, early-stage trial with only 92 participants, so results may not apply widely. The supplement may not significantly improve outcomes over placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT HIV POSITIVE WOMEN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instituto Nacional de Perinatologia
Mexico City, Mexico City, 11000, Mexico